Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 514

1.

Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels.

Choi M, Lee HS, Naidansaren P, Kim HK, O E, Cha JH, Ahn HY, Yang PI, Shin JC, Joe YA.

Int J Biochem Cell Biol. 2013 Mar;45(3):560-70. doi: 10.1016/j.biocel.2012.12.001. Epub 2012 Dec 12.

PMID:
23246593
2.

Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.

Zhang J, Chen GH, Wang YW, Zhao J, Duan HF, Liao LM, Zhang XZ, Chen YD, Chen H.

Chin Med J (Engl). 2012 Oct;125(19):3472-8.

PMID:
23044308
3.

Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis.

Hsieh JY, Wang HW, Chang SJ, Liao KH, Lee IH, Lin WS, Wu CH, Lin WY, Cheng SM.

PLoS One. 2013 Aug 22;8(8):e72604. doi: 10.1371/journal.pone.0072604. eCollection 2013.

4.
5.

Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ.

Cell Tissue Res. 2011 Oct;346(1):53-64. doi: 10.1007/s00441-011-1249-8. Epub 2011 Oct 11.

PMID:
21987220
6.

Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.

Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.

J Med Assoc Thai. 2013 Sep;96(9):1208-17.

PMID:
24163998
7.

Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.

Amiri F, Halabian R, Dehgan Harati M, Bahadori M, Mehdipour A, Mohammadi Roushandeh A, Habibi Roudkenar M.

Hematology. 2015 May;20(4):208-16. doi: 10.1179/1607845414Y.0000000185. Epub 2014 Aug 12.

PMID:
25116042
8.

Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.

Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW.

Stem Cells Dev. 2010 Dec;19(12):1895-910. doi: 10.1089/scd.2009.0485. Epub 2010 Oct 12.

PMID:
20367285
9.

Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.

He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A.

Tissue Eng Part A. 2014 Apr;20(7-8):1314-24. doi: 10.1089/ten.TEA.2013.0333. Epub 2014 Mar 14.

PMID:
24279891
10.

Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity.

Bai J, Hu Y, Wang YR, Liu LF, Chen J, Su SP, Wang Y.

J Geriatr Cardiol. 2012 Jun;9(2):166-71. doi: 10.3724/SP.J.1263.2011.12091.

11.

Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.

Corotchi MC, Popa MA, Remes A, Sima LE, Gussi I, Lupu Plesu M.

Stem Cell Res Ther. 2013 Jul 11;4(4):81. doi: 10.1186/scrt232.

12.

Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.

Chen MY, Lie PC, Li ZL, Wei X.

Exp Hematol. 2009 May;37(5):629-40. doi: 10.1016/j.exphem.2009.02.003.

PMID:
19375653
13.

Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.

van der Garde M, van Pel M, Millán Rivero JE, de Graaf-Dijkstra A, Slot MC, Kleinveld Y, Watt SM, Roelofs H, Zwaginga JJ.

Stem Cells Dev. 2015 Nov 15;24(22):2649-59. doi: 10.1089/scd.2015.0138. Epub 2015 Oct 8.

14.

Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.

Lee HS, Kim KS, Lim HS, Choi M, Kim HK, Ahn HY, Shin JC, Joe YA.

J Cell Biochem. 2015 Feb;116(2):310-9. doi: 10.1002/jcb.24969.

PMID:
25185536
15.

Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.

Cóndor JM, Rodrigues CE, Sousa Moreira Rd, Canale D, Volpini RA, Shimizu MH, Camara NO, Noronha Ide L, Andrade L.

Stem Cells Transl Med. 2016 Aug;5(8):1048-57. doi: 10.5966/sctm.2015-0138. Epub 2016 Jun 8.

16.

Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.

Zhang W, Liu XC, Yang L, Zhu DL, Zhang YD, Chen Y, Zhang HY.

Coron Artery Dis. 2013 Nov;24(7):549-58. doi: 10.1097/MCA.0b013e3283640f00.

PMID:
23892469
17.

Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.

Tsai PJ, Wang HS, Lin GJ, Chou SC, Chu TH, Chuan WT, Lu YJ, Weng ZC, Su CH, Hsieh PS, Sytwu HK, Lin CH, Chen TH, Shyu JF.

Cell Transplant. 2015;24(8):1555-70. doi: 10.3727/096368914X683016. Epub 2014 Jul 15.

PMID:
25198179
18.

MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells.

Chang SJ, Weng SL, Hsieh JY, Wang TY, Chang MD, Wang HW.

BMC Med Genomics. 2011 Sep 19;4:65. doi: 10.1186/1755-8794-4-65.

19.

Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells.

Liu Y, Deng B, Zhao Y, Xie S, Nie R.

Dev Growth Differ. 2013 Jun;55(5):591-605. doi: 10.1111/dgd.12052. Epub 2013 Apr 4.

PMID:
23557080
20.

Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.

Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M.

Stem Cells Dev. 2010 Jan;19(1):117-30. doi: 10.1089/scd.2009.0177.

PMID:
19619003

Supplemental Content

Support Center